Lung cancer

Lung cancer (pulmonary carcinoma) is one of the most common cancers worldwide and the leading cause of cancer-related deaths globally. The diagnostic and therapeutic options for lung cancer have expanded significantly in recent years. Keep reading for latest developments in screening, biomarker testing, treatment innovations, and ongoing research.

News • Early thoracic malignancy screening

Developing a breath test for lung cancer with biosensors and AI

A biosensor that identifies volatile organic compounds (VOCs) in exhaled breath could be used in conjunction with AI to detect various thoracic cancers including lung cancer.

News • Estimation of nodule malignancy risk

Lung cancer screening: AI to reduce false positives

Misinterpreting the malignancy risk of lung nodules often results in high false-positive rates, unnecessary follow-ups, increased patient anxiety and healthcare costs. A new study suggests that AI…

News • EGFR-mutated non-small cell lung cancer

NSCLC: Surgical combination therapy may prolong disease control

In metastatic EGFR-mutated non-small cell lung cancer (NSCLC), targeting residual disease through surgery can extend the benefits of EGFR TKI therapy beyond standard monotherapy, a new study finds.

Article • From H&E to multiplex

Self-learning AI: a boost for digital pathology

Self-learning artificial intelligence approaches are offering a number of advantages for digital pathology when compared to established AI options. The benefits, which range from greater speed and…

News • Research on Antrodia cinnamomea

Promising fungal compound to fight cancer and inflammation

Studies have found that natural polysaccharides from a medical fungus endemic to Taiwan can not only effectively inhibit inflammation, but also fight the proliferation of lung cancer cells.

News • NHS rollout

Liquid biopsy: new ‘blood test-first’ approach for lung cancer

A new ‘liquid biopsy’ test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping avoid further tests and treatments including chemotherapy.

Article • Launch of new national program

A new “impulse” for equitable lung cancer screening in France

Lung cancer is the leading cause of cancer death in the EU, yet no organized screening program exists to detect the disease before symptoms appear. This September, France will strike back with an ambitious pilot program that could boost European lung cancer screening. Professor Marie-Pierre Revel presented the details at the French Thoracic Imaging Society Spring Days in Marseille, highlighting…

News • Deep learning-based assessment

AI ‘Sybil’ predicts lung cancer risk from single LDCT scan

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT (LDCT) scan, according to new research published at the ATS 2025 International Conference.

News • Patient history analysis

AI helps GPs detect lung cancer 4 months earlier

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier with an algorithm created by researchers based on the data of more than half a million patients.

News • Study shows GP imaging benefits

Lung fibrosis: radiopharmaceutical improves diagnosis and monitoring

Nuclear medicine specialists have successfully used the radiopharmaceutical Ga-68-Trivehexin from Trimt to accurately diagnose patients with pulmonary fibrosis and concurrent lung cancer.

News • Intrinsic electrical activity drives cancer progression

SCLC: Deciphering the unusual aggressiveness of small cell lung cancer

New research reveals that self-generated electrical activity of small cell lung cancer (SCLC) directly promotes tumor metastasis and progression. This may provide new avenues for future treatments.

News • LDCT rule-out

AI shows potential for workload reduction in lung cancer screening

A new study reveals that AI can accurately rule out negative low-dose CT (LDCT) scans, potentially reducing the workload of radiologists in lung cancer screening by up to 79%.

News • Quantification of serum biomarkers

Early detection of lung cancer with low-cost biosensor

A sensor, similar to glucose monitoring devices, detects lung cancer biomarkers from a blood sample in just 40 minutes. The technology has potential to identify at-risk patients and tailor treatments.

News • Automated tumor detection and segmentation

Deep learning helps detect lung cancer on CT

A new deep learning model shows promise in detecting and segmenting lung tumors. The findings of the study could have important implications for lung cancer treatment.

News • Early-stage disease stratification

Predicting lung cancer outcomes with tumour DNA in the blood

A new personalised oncology platform has been tested to detect circulating tumour DNA (ctDNA) in patients with lung adenocarcinoma before surgery, to predict their risk of cancer relapse.

News • Coronary artery disease detection

Low-dose chest CT may detect more than just lung cancer

As new research shows, low-dose chest computed tomography (CT) can identify coronary artery calcium, a strong risk factor for coronary artery disease (CAD), in patients without cardiac symptoms.

News • Interstital lung disease

Lung cancer: PET/CT imaging analysis with AI predicts immunotherapy side effects

PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, a serious side effect of immunotherapy in lung cancer, a new study shows.

News • Research on new sensing mechanism

Finding signs of lung cancer in exhaled breath

Researchers from China have developed ultrasensitive, nanoscale sensors that in small-scale tests distinguished a key change in the chemistry of the breath of people with lung cancer.

News • Experts propose combination strategy

Kidney cancer: early detection through 'piggyback' screening

Kidney cancer is relatively rare, so dedicated screening programmes would not be cost-effective. Combined with lung cancer screening, however, this would be much more feasible, a new study shows.

News • Strengthening the immune defense

STAb-T: new immunotherapy method shows promise against lung cancer

STAb-T, a new form of immunotherapy to treat solid tumours shows therapeutic potential in animal models with non-small cell lung cancer. The new strategy is designed to strengthen the defensive cells.

News • COPD and asthma

Certain lung conditions could "mask" lung cancer, delay diagnosis

Certain long-term health conditions such as chronic obstructive pulmonary disease (COPD) and asthma, can obscure early symptoms of lung cancer, leading to delays in diagnosis, a new study finds.

News • Automated tissue analysis

Digital pathology: AI platform to improve lung cancer diagnosis

Cologne researchers have developed an AI-based digital pathology platform to enable extremely fast and accurate fully automated analysis of tissue sections from lung cancer patients.

Article • AI is key

Lung cancer screening initiatives across Europe

Artificial Intelligence will be a critical component in ensuring a Europe-wide lung cancer screening programme can achieve its potential, according to speakers at a special ECR 2024 session. Delegates heard that the SOLACE project (Strengthening the screening of Lung Cancer in Europe) will be supported by AI in terms of workflow, diagnostics, and image and data analysis.

News • Digital support

New app triples chance to quit smoking

Finnish researchers found that using a mobile application based on cognitive behavioral therapy can significantly boost success rates of people attempting to stop smoking.

139 show more articles